8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Extremely Low Frequency Magnetic Fields Induce mTOR and Hsa_Circ_100338 Expression Changes in Gastric Cancer and Normal Fibroblast Cell Lines

Bioeffects Seen

Authors not listed · 2022

Share:

Specific ELF magnetic field strengths may selectively harm gastric cancer cells while protecting normal cells.

Plain English Summary

Summary written for general audiences

Researchers exposed normal and gastric cancer cells to extremely low frequency magnetic fields at different intensities for 18 hours. They found that specific field strengths (0.25 and 0.5 millitesla) reduced cancer cell viability while boosting normal cell health, and decreased expression of genes linked to tumor growth and spread. This suggests certain EMF exposures might have therapeutic potential against gastric cancer.

Why This Matters

This study presents intriguing evidence that extremely low frequency magnetic fields might selectively target cancer cells while sparing healthy tissue. The researchers found that specific field strengths between 0.25 and 0.5 millitesla reduced both cancer cell viability and expression of mTOR, a key protein that drives tumor growth. What makes this particularly interesting is the differential response: normal fibroblast cells actually became more viable under these same conditions.

To put these exposure levels in perspective, 0.25-0.5 millitesla represents relatively strong magnetic fields compared to typical household exposures, which usually measure in microtesla. While this research explores therapeutic applications rather than safety concerns, it demonstrates that EMF effects are highly dependent on frequency, intensity, and cell type. The science shows that electromagnetic fields can have profound biological impacts, reinforcing why we need more research into both the risks and potential benefits of EMF exposure.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2022). Extremely Low Frequency Magnetic Fields Induce mTOR and Hsa_Circ_100338 Expression Changes in Gastric Cancer and Normal Fibroblast Cell Lines.
Show BibTeX
@article{extremely_low_frequency_magnetic_fields_induce_mtor_and_hsacirc100338_expression_changes_in_gastric_cancer_and_normal_fibroblast_cell_lines_ce4138,
  author = {Unknown},
  title = {Extremely Low Frequency Magnetic Fields Induce mTOR and Hsa_Circ_100338 Expression Changes in Gastric Cancer and Normal Fibroblast Cell Lines},
  year = {2022},
  doi = {10.22074/cellj.2022.7922},
  
}
DOI: 10.22074/cellj.2022.7922PubMed: 36043404

Quick Questions About This Study

Yes, this study found that 0.25 millitesla ELF magnetic fields significantly decreased gastric cancer cell viability after 18 hours of exposure, while normal fibroblast cells remained unharmed or even showed improved survival rates.
ELF magnetic fields at 0.25 and 0.5 millitesla significantly decreased mTOR expression in gastric cancer cells. Since mTOR promotes cell growth and proliferation, this reduction could help inhibit tumor development and progression.
Yes, normal fibroblast cells showed increased viability and mTOR expression under most magnetic field strengths, while gastric cancer cells showed decreased viability and mTOR expression at lower intensities, suggesting selective therapeutic potential.
The circular RNA hsa_circ_100338 was downregulated at 0.25 millitesla in both cell types, then increased as magnetic field strength increased. This pattern occurred in both normal and cancer cells.
Based on this study, 0.25 millitesla appears most promising, as it reduced both cancer cell viability and expression of growth-promoting genes while maintaining or improving normal cell health.